Teva says Israel-Hamas war not hurting production, eyes growth in 2024 | Reuters
Former Teva officials said to return $50m over fines paid by drugmaker | The Times of Israel
Israeli pharmaceutical giant Teva investigating bribery accusations in Romania | The Times of Israel
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Exclusive: Teva to fire 500 managers in Israel - Globes
Jewish Values Investors JLens Target Israeli Company
Teva to axe 14,000 jobs despite uproar in Israel
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
These Israeli pharmaceutical stocks are down in the wake of Hamas attack - MarketWatch
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Israeli pharma giant Teva to launch biosimilar version of AbbVie's Humira in 2024 | HealthCare Middle East & Africa Magazine
Teva Israel | Brand Presentation :: Behance
Teva Pharmaceuticals Headquarters Israel Discount | kaartech.com
Israel Not Aiming to Punish Teva on Job Cuts, Official Says - Bloomberg
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
Teva enlarges workforce for first time since 2016 - Globes
Teva Pharmaceutical set for major layoffs in Israel, US: Report, ET HealthWorld
Teva Pharmaceutical Industries' cuts put UK jobs at risk
Israel Fights Back on Teva Job Cuts - WSJ
Teva moves to cut hundreds of manufacturing jobs in Israel | Fierce Pharma
Brussels' Teva probe reveals dark side of patent protections
Israeli Teva reaches proposed $4.35 bln settlement of US opioid lawsuits - The Jerusalem Post
Teva drops migraine-drug patent case against Eli Lilly | Reuters
An Israeli pharma champion sickens
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
